Lightship Partners with Castor to Scale Virtual Trials

Article

Lightship and Castor have announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale.

For decades, clinical trials have experienced low rates of participation relative to the distribution of a condition, which can impact the ability to access diverse patient populations and construct a representative sample. One of the main reasons for this is the high burden of participation that patients often experience. Lightship’s delivery model combined with an in-house care team will provide the patient experience in clinical trials partnering with Castor’s globally compliant Decentralized Clinical Trial and Clinical Data Management platform.

For more information, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.